Table 4

Association between dietary intake of vitamin D, omega-3 FA, folate and EULAR response after 3 months

Nutrient intakenOR (95 % CI)
Age and sex adjustment
OR (95 % CI)
Multivariable adjustment
Vitamin D727
 First quartile: ≤4.25 µg/day1821.001.00
  Second quartile: 4.26–5.42 µg/day1701.07 (0.70 to 1.64)0.94 (0.59 to 1.50)
  Third quartile: 5.43–6.96 µg/day1841.15 (0.75 to 1.77)1.11 (0.70 to 1.76)
  Fourth quartile: >6.97 µg/day1911.75 (1.13 to 2.71)1.61 (1.01 to 2.57)
  p Value, quartile 4 vs 10.0120.048
Omega-3 FA727
  First quartile: ≤0.45 g/day1801.001.00
  Second quartile: 0.46–0.62 g/day1921.25 (0.82 to 1.89)1.28 (0.82 to 2.00)
  Third quartile: 0.63–0.83 g/day1831.35 (0.89 to 2.07)1.35 (0.85 to 2.13)
  Fourth quartile: >0.84 g/day1721.64 (1.07 to 2.53)1.68 (1.05 to 2.68)
  p Value, quartile 4 vs 10.0240.030
Folate727
  First quartile: ≤244.88 µg/day2011.001.00
  Second quartile: 244.89–296.86 µg/day1821.32 (0.88 to 1.99)1.40 (0.90 to 2.16)
  Third quartile: 296.87–365.70 µg/day1931.59 (1.07 to 2.38)1.66 (1.07 to 2.58)
  Fourth quartile: >365.71 µg/day1511.14 (0.74 to 1.75)1.11 (0.69 to 1.79)
  p value, quartile 4 vs 10.5570.672
  • Multivariable adjustment for age (11 5-year age groups), sex, smoking pack-years, total energy intake (tertiles), supplementation (vitamin D, omega-3 FA/fish oil and folic acid), BMI (continuous), education level (high school and university) and PA (sedentary PA, moderate occasional PA, moderate regular PA and regular exercise), DAS28 at baseline (continuous) and use of DMARDs and GC baseline (yes or no).

  • p Value: comparison between fourth and first quartiles.

  • BMI, body mass index; DAS28, 28-joint Disease Activity Score; DMARDs, disease-modifying antirheumatic drugs; EULAR, European League Against Rheumatism; FA, fatty acid; GC, glucocorticoids; PA, physical activity.